Journal of Substance Abuse Treatment
Volume 29, Issue 4 , Pages 295-306 , December 2005

Methamphetamine treatment: Trends and predictors of retention and completion in a large state treatment system (1992–2002)

Received 7 March 2005 ,Revised 6 May 2005 ,Accepted 23 August 2005.

References 

  1. Anglin MD, Kalechstein A, Maglione M, Annon J, Fiorentine R. Epidemiology and treatment of methamphetamine abuse in California: A regional report. Hyattsville: National Evaluation Data and Technical Assistance Center Contract No. 270-94-0001; Center for Substance Abuse Treatment, Department of Health and Human Services; 1998;
  2. Anglin MD, Perrochet B. Drug use and crime: A historical review of research conducted by the UCLA Integrated Substance Abuse Programs. Substance Use & Misuse. 1998;33:1871–1914
  3. Benda B. Factors associated with rehospitalization among veterans in a substance abuse treatment program. Psychiatric Services. 2002;53:1176–1178
  4. Brecht, M.- L., Greenwell, L., von Mayrhauser, C., Anglin, M. D. (in press). Two-year outcomes of treatment for methamphetamine use. Journal of Psychoactive Drugs.
  5. Brecht M-L, O'Brien A, von Mayrhauser C, Anglin MD. Methamphetamine use behaviors and gender differences. Addictive Behaviors. 2004;29:89–106
  6. Brewer D, Catalano R, Haggerty K, Gainey R, Fleming C. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction. 1998;93:73–92
  7. Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research. 1999;34:791–806
  8. Brown V, Melchoir A, Waite-O'Brien N, Huba G. Effects of women-sensitive, long-term residential treatment on psychological functioning of diverse populations of women. Journal of Substance Abuse Treatment. 2002;23:133–144
  9. Carise D, McLellan AT, Gifford L, Kleber H. Developing a national addiction treatment information system. An introduction to the Drug Evaluation Network System. Journal of Substance Abuse Treatment. 1999;17:67–77
  10. Comfort M, Sockloff A, Loveroo J, Kaltenbach K. Multiple predictors of substance-abusing women's treatment and life outcomes: A prospective longitudinal study. Addictive Behaviors. 2003;28:199–224
  11. Diggle P, Heagerty P, Liang K-Y, Zeger S. Analysis of longitudinal data. New York, NY: Oxford University Press; 2002;
  12. Drug Enforcement Agency (DEA) . State factsheets. Available at http://www.dea.gov/pubs/state_factsheets.html2004;(Accessed 7/31/2005)
  13. Fletcher B, Battjes R. Introduction to the special issue: Treatment process in DATOS. Drug and Alcohol Dependence. 1999;57:81–87
  14. Gonzalez Castro F, Barrington EH, Walton MA, Rawson RA. Cocaine and methamphetamine: Differential addiction rates. Psychology of Addictive Behaviors. 2000;14:390–396
  15. Gossop M, Marsden J, Stewart D. Treatment outcomes of stimulant misusers: One year follow-up results from the National Treatment Outcomes Research Study (NTORS). Addictive Behaviors. 2000;25:509–522
  16. Gossop M, Marsden J, Stewart D, Kidd T. Changes in use of crack cocaine after drug misuse treatment: 4–5 Year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Dependence. 2002;66:21–28
  17. Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4–5 Year follow-up results. Addiction. 2003;98:291–303
  18. Greenfield S, Kolodziej M, Sugarman D, Muenz L, Vagge L, He D, et al. History of abuse and drinking outcomes following inpatient alcohol treatment: A prospective study. Drug and Alcohol Dependence. 2002;67:227–234
  19. Greenwood G, Woods W, Guydish J, Bein E. Relapse outcomes in a randomized trial of residential and day drug abuse treatment. Journal of Substance Abuse Treatment. 2001;20:15–23
  20. Grella C. Women in residential drug treatment: Differences by program type and pregnancy. Journal of Health Care for the Poor and Underserved. 1999;10:216–229
  21. Grella C, Joshi V, Hser Y-I. Program variation in treatment outcomes among women in residential treatment. Evaluation Review. 2000;24:364–383
  22. Halkitis P, Parsons J, Stirratt M. A double epidemic: Crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality. 2001;41:17–35
  23. Harrison P, Asche S. Outcomes monitoring in Minnesota: Treatment implications, practical limitations. Journal of Substance Abuse Treatment. 2001;21:173–183
  24. Hawke J, Jainchill N, De Leon G. Adolescent amphetamine users in treatment: Client profiles and treatment outcomes. Journal of Psychoactive Drugs. 2000;23:95–105
  25. Hiller M, Knight K, Broome K, Simpson D. Legal pressure and treatment retention in a national sample of long-term residential programs. Criminal Justice and Behavior. 1998;25:463–481
  26. Hohman M, Oliver R, Wright W. Methamphetamine abuse and manufacture: The child welfare response. Social Work. 2004;49:373–381
  27. Hser Y-I, Evans E, Huang D, Anglin MD. Relationship between drug treatment services, retention, and outcomes. Psychiatric Services. 2004;55:767–774
  28. Hser Y-I, Evans E, Teruya C, Ettner S, Hardy M, Urada D, et al. The California Treatment Outcomes Study (CalTOP) final report. Los Angeles, CA: UCLA Integrated Substance Programs; 2003;
  29. Hser Y-I, Grella C, Hsieh S, Anglin MD, Brown B. Prior treatment experience related to process and outcomes in DATOS. Drug and Alcohol Dependence. 1999;57:137–150
  30. Hser Y-I, Huang Y, Chou C-P, Anglin MD. Longitudinal patterns of treatment utilization and outcomes among methamphetamine abusers: A growth curve modeling approach. Journal of Drug Issues. 2003;33:921–938
  31. Hubbard R, Craddock S, Anderson J. Overview of 5-year follow-up outcomes in the Drug Abuse Treatment Outcome Studies (DATOS). Journal of Substance Abuse Treatment. 2003;25:125–134
  32. Joe GW, Simpson DD, Broome KM. Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence. 1999;57:113–125
  33. Kalechstein A, Newton TF, Longshore D, van Gorp WG, Anglin MD. Psychiatric comorbidity in methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences. 2000;12:480–484
  34. King AC, Canada SA. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. Journal of Substance Abuse Treatment. 2004;26:189–195
  35. Kingree JB. Understanding gender differences in psychosocial functioning and treatment retention. American Journal of Drug and Alcohol Abuse. 1995;21:267–281
  36. London E, Simon S, Berman S, Mandelkern M, Lichtman A, Bramen J, et al. Mood disturbances and regional metabolic abnormalities in recently abstinent methamphetamine users. Archives of General Psychiatry. 2004;61:73–84
  37. Longshore D, Evans E, Urada D, Teruya C, Hardy M, Hser Y-I, et al. Evaluation of the Substance Abuse and Crime Prevention Act 2002 report. Los Angeles: UCLA Integrated Substance Abuse Programs; 2003;
  38. Maglione M, Chao B, Anglin D. Correlates of outpatient drug treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs. 2000;32:221–228
  39. Maglione M, Chao B, Anglin D. Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994–1997. Addiction Research. 2000;8:65–79
  40. Marwick C. NIDA seeking data on effect of fetal exposure to methamphetamine. Journal of the American Medical Association. 2000;28:2225–2226
  41. McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence. 2001;62:9–17
  42. McKay J, Weiss R. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Evaluation Review. 2001;25:113–161
  43. Mertens JR, Weisner CM. Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism, Clinical and Experimental Research. 2000;24:1525–1533
  44. Molitor F, Ruiz J, Flynn N, Mikanda J, Sun R, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug and Alcohol Abuse. 1999;25:475–493
  45. National Drug Intelligence Center (NDIC) . National drug threat assessment. Washington, DC: U. S. Department of Justice; 2004;Available at http://www.usdoj.gov/ndic/pubs8/8731/8731p.pdf(Accessed 7/31/2005)
  46. National Institute of Justice (NIJ) . ADAM: 1998 Annual report on methamphetamine use among arrestees. Washington, DC: U.S. Department of Justice; 1999;
  47. National Institute of Justice (NIJ) . ADAM: Annualized site reports 2001. Washington, DC: U.S. Department of Justice; 2003;http://www.ncjrs.org/ondcppubs/publications/policy/ndcs00/strategy2000.pdf(Accessed 7/31/2005)
  48. Office of the National Drug Control Policy (ONDCP) . Pulse check: Trends in drug abuse January–June 2002. Washington, DC: The White House; 2002;
  49. Prendergast M, Podus D, Chang E. Program factors and treatment outcomes in drug dependence treatment: An examination using meta-analysis. Substance Use & Misuse. 2000;35:1931–1965
  50. Prendergast M, Podus D, Chang E, Urada D. The effectiveness of drug abuse treatment: A meta-analysis of comparison group studies. Drug and Alcohol Dependence. 2002;67:53–72
  51. Rawson R, Crevecouer D. Los Angeles County Evaluation System annual report. Los Angeles: UCLA Integrated Substance Abuse Programs; 2005;
  52. Rawson R, Gonzales R, Brethen P. Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment. 2002;23:145–150
  53. Rawson R, The Methamphetamine Treatment Project Corporate Authors . A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99:708–717
  54. Reback C, Larkins S, Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS and Behavior. 2004;8:87–98
  55. Rowan-Szal G, Joe G, Simpson D. Treatment retention of crack and cocaine users in a national sample of long term residential clients. Addiction Research. 2000;8:51–64
  56. SAMHSA (Substance Abuse and Mental Health Services Administration), Office of Applied Statistics . Treatment Episode Data Set (TEDS): 1992–2002. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-23, DHHS Publication No. (SMA) 04-3965, Rockville, MD. Available at http://www.oas.samhsa.gov/dasis.htm2004;(Accessed 7/31/2005)
  57. Schildhaus S, Gerstein D, Dugoni B, Brittingham A, Cerbone F. Services research outcomes study: Explanation of treatment effectiveness, using individual-level and programmatic variables. Substance Use & Misuse. 2000;35:1879–1910
  58. Shoptaw S, Peck J, Reback C, Rotheram-Fuller E. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. Journal of Psychoactive Drugs. 2003;35(Suppl 1):161–168
  59. Simon S, Berman S, Dacey J, Ling W, Rawson R, London E. Logical reasoning in methamphetamine abusers during the first month of abstinence. In: Presented at College on Problems of Drug Dependence, June. 2004;
  60. Simpson D, Joe G, Fletcher B, Hubbard R, Anglin MD. A national evaluation of treatment outcomes for cocaine dependence. Archives of General Psychiatry. 1999;56:507–514
  61. Smith L, Yonekura M, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. Developmental and Behavioral Pediatrics. 2003;24:17–23
  62. Stewart J, Meeker J. Fetal and infant deaths associated with maternal methamphetamine abuse. Journal of Analytical Toxicology. 1997;21:515–517
  63. Strauss SM, Falkin GP. The relationship between the quality of drug user treatment and program completion: Understanding the perceptions of women in a prison-based program. Substance Use & Misuse. 2000;35:2127–2159
  64. Swalwell C, Davis G. Methamphetamine as a risk factor for acute aortic dissection. Journal of Forensic Sciences. 1999;44:23–26
  65. The TOPPS II Interstate Cooperative Study Group. Drug treatment completion and post-discharge employment in the TOPPS-II Interstate Cooperative Study. Journal of Substance Abuse Treatment. 2003;25:9–18
  66. Travis J, Vareen D. Final report, Methamphetamine Interagency Task Force. Washington, DC: National Institute of Justice; 2000;Available on the Internet at http://www.ncjrs.org/pdffiles1/nij/180155.pdf(Accessed 7/31/2005)
  67. von Mayrhauser C, Brecht M-L, Anglin MD. Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: An emerging profile. Journal of Addictive Diseases. 2002;21:45–60
  68. Weisner C, Matzger H, Kaskutas L. How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals. Addiction. 2003;98:901–911
  69. Zernike K. The orphans of methamphetamines strain foster care. New York Times; 2005, July 12;Available at http://www.nytimes.com/2005/07/11/national/11meth.html?ex=1es278734400$en=aba0680fe2a307es$ei=5088$partner=rssnyt$emc=rss.html(Accessed 9/28/2005)
  70. Zhang Z, Friedmann P, Gerstein D. Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003;98:673–684

PII: S0740-5472(05)00172-8

doi: 10.1016/j.jsat.2005.08.012

Journal of Substance Abuse Treatment
Volume 29, Issue 4 , Pages 295-306 , December 2005

Article Tools

* Image Usage & Resolution